Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    -10.00 (-0.43%)
Bid:
2,320.00
Ask:
2,325.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

15 Sep 2023 07:00

RNS Number : 5208M
RIT Capital Partners PLC
15 September 2023
Β 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

Β 

15 September 2023

Β 

31 August 2023 Net Asset Value

Β 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 31 August 2023 (with debt at fair value) was 2,399p per Β£1 ordinary share (31 July 2023: 2,402p).

Β 

Β 

August 2023 Highlights

Β 

A faster acceleration in global bond yields caused a meaningful downdraft in global equity markets. In the US, for example, Fitch Ratings' downgrade of the United States' credit rating, the Treasury's higher than expected borrowing intentions and robust economic data led to higher government yields. This in turn pushed down equity markets, with the MSCI ACWI (50% Β£) declining nearly -2% during the month. Renewed concerns over the Chinese economy, especially around the weak property sector and lack of stimulus, drove Chinese stocks lower (CSI 300 -6%). Against that backdrop, our portfolio finished approximately flat for the month, as our low quoted equity exposure, hedging and currency positioning shielded us from the large market declines.

Β 

Β· Our Quoted Equities book detracted during the month, with the decrease driven mainly by Chinese holdings, partly offset by positive contributions from Japanese holdings and gains in share prices of quality businesses such as Tempur Sealy and Mastercard.

Β· Private Investments also detracted slightly, driven by updated marks from our private fund positions. As of 31 August, approximately 80% of our private funds had reported valuations to 30 June and approximately 20% were held at 31 March valuations.

Β· Our Uncorrelated Strategies book contributed positively during the month, driven by healthy contributions from our positions in carbon credits and market neutral strategies.

Β· The Board continued its active buyback programme, generating a further accretive impact to the NAV per share. In the month of August, the Company repurchased approximately 0.9 million shares on behalf of shareholders.

Β· The Company continues to maintain a strong liquidity position.

Β 

Β 

For more information:

J. Rothschild Capital Management (Investment Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

Β 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

Β 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

Β 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Tom Burns

T:Β 020 7404 5959E:Β RIT@BrunswickGroup.comΒ 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NAVDZLFFXKLFBBZ
Date   Source Headline
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:00 amRNSTransaction in Own Shares
28th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 202312:23 pmRNSTotal Voting Rights
27th Mar 20237:00 amRNSTransaction in Own Shares
24th Mar 20237:00 amRNSTransaction in Own Shares
23rd Mar 20237:00 amRNSTransaction in Own Shares
22nd Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSTransaction in Own Shares
20th Mar 20237:00 amRNSTransaction in Own Shares
17th Mar 20237:00 amRNSTransaction in Own Shares
16th Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 20237:00 amRNSTransaction in Own Shares
14th Mar 20237:00 amRNSNet Asset Value(s)
13th Mar 202312:51 pmRNSUpdate on Silicon Valley Bank
8th Mar 20231:21 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSTransaction in Own Shares
7th Mar 20237:00 amRNSTransaction in Own Shares
6th Mar 20237:00 amRNSTransaction in Own Shares
3rd Mar 20237:00 amRNSTransaction in Own Shares
2nd Mar 20237:00 amRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTransaction in Own Shares
28th Feb 20237:00 amRNSAnnual Financial Report
20th Feb 20237:00 amRNSNet Asset Value(s)
9th Feb 20235:00 pmRNSComposition of Board Committee
7th Feb 20237:00 amRNSNet Asset Value(s)
21st Dec 202212:52 pmRNSDirector/PDMR Shareholding
21st Dec 20227:00 amRNSTransaction in Own Shares
19th Dec 20225:20 pmRNSDirector/PDMR Shareholding
19th Dec 20227:00 amRNSTransaction in Own Shares
16th Dec 20227:00 amRNSTransaction in Own Shares
15th Dec 20227:00 amRNSNet Asset Value(s)
8th Dec 20227:00 amRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 20227:00 amRNSTransaction in Own Shares
15th Nov 20227:00 amRNSNet Asset Value(s)
14th Oct 20227:00 amRNSNet Asset Value(s)
3rd Oct 20227:00 amRNSTransaction in Own Shares
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20227:00 amRNSTransaction in Own Shares
26th Sep 20227:00 amRNSTransaction in Own Shares
20th Sep 20227:00 amRNSTransaction in Own Shares
16th Sep 20227:00 amRNSTransaction in Own Shares
14th Sep 20227:00 amRNSNet Asset Value(s)
7th Sep 20227:00 amRNSTransaction in Own Shares
6th Sep 20227:00 amRNSTransaction in Own Shares
17th Aug 20225:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.